The Effect of Necitumumab in Combination with Gemcitabine-Cisplatin on Health-Related Quality of Life (HRQOL) and Tolerability: Squire Trial Patients with Epidermal Growth Factor Receptor (EGFR)-Expressing Squamous NSCLC Tumours
Year: 2016
Type: article
Source: Value in Health
Authors: M Reck, M Socinski, A Szczesna, M Dediu, R Ramlau, G Losonczy, O Molinier, C Schumann, J Brown, Soldatenkova, N Chouaki, N Thatcher, A Luft
Institutions: German Center for Lung Research, LungenClinic Grosshansdorf, University of Pittsburgh Medical Center, Institutul Oncologic Bucuresti, Poznan University of Medical Sciences, Semmelweis University, Centre Hospitalier du Mans, Eli Lilly (United Kingdom), Eli Lilly (Germany), Eli Lilly (United States), The Christie Hospital
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2540333400